Physician

John Michael Kasey, DO

According to 2025 Medicare claims, John Kasey, DO (NPI: 1831371368) practices nephrology in the Huntington-Ashland, WV-KY-OH market, with the plurality of this provider's patient population coming from Lawrence, OH. This provider's primary affiliated billing organization is KINGS DAUGHTERS MEDICAL SPECIALTIES INC (NPI: 1184912453; TIN: 264183569) and primary practice location at 41101-2843.

Kasey's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 471 traditional Medicare patients, billed 1,590 HCPCS/CPT codes, and received $140,447 in Medicare payments. The top billing code was 99222 (Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes). Part D data shows 3,038 prescription claims across 507 beneficiaries totaling $518,808 in drug costs, led by Tolvaptan (Tolvaptan). DME data shows 12 claims. Open Payments data shows 12 records totaling $247. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has fallen sharply in recent years, from $321,137 to $140,447. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $759,599 and ending at $518,808. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $3,707 and ending at $3,935.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,036	3,803	$321,137
2016	1,039	3,874	$336,582
2017	1,071	3,953	$310,754
2018	1,048	3,711	$303,380
2019	1,009	3,479	$297,760
2020	773	3,119	$255,112
2021	697	2,798	$237,774
2022	623	2,115	$190,913
2023	488	1,510	$146,959
2024	471	1,590	$140,447

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	388	4,642	$759,599
2016	439	4,619	$743,267
2017	473	4,764	$739,855
2018	466	4,184	$534,248
2019	458	3,813	$546,115
2020	442	3,677	$860,741
2021	507	3,605	$973,970
2022	509	3,401	$724,664
2023	506	3,275	$617,988
2024	507	3,038	$518,808

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	27	$1,702
2016	N/R	24	$939
2017	N/R	94	$2,201
2018	N/R	109	$3,080
2019	N/R	135	$6,001
2020	N/R	76	$2,195
2021	N/R	53	$2,685
2022	N/R	44	$2,607
2023	N/R	15	$188
2024	N/R	12	$257

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99222	Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes	78	85	$95
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	42	42	$91
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	37	94	$88
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	230	415	$64
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	199	615	$58

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Tolvaptan	Tolvaptan	20	480	$108,264
Farxiga	Dapagliflozin Propanediol	98	4,535	$80,969
Velphoro	Sucroferric Oxyhydroxide	19	870	$61,953
Auryxia	Ferric Citrate	14	720	$51,622
Sevelamer Carbonate	Sevelamer Carbonate	44	2,265	$5,473

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A7038	Filter, disposable, used with positive airway pressure device	N	N/R	12	$257

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	12	$247	Otsuka America Pharmaceutical, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for John Michael Kasey, DO?

Tedicare shows public-source Medicare data for John Michael Kasey, DO (NPI 1831371368), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does John Michael Kasey, DO have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to John Michael Kasey, DO?

John Michael Kasey, DO is linked to KINGS DAUGHTERS MEDICAL SPECIALTIES INC (billing NPI 1184912453) in the available physician profile data.

Does John Michael Kasey, DO have Open Payments data?

John Michael Kasey, DO has 12 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.